Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00656318 · ClinicalTrials.gov registry record
Impact of Oral Contraceptives on GABA and Neurosteroids
A clinical trial, sponsored by Yale University.
- Terminated
- Registry status
- 6
- Enrollment target
NCT00656318: Clinical Trial study, sponsored by Yale University.
NCT00656318 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00656318 was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Thus, the proposed study has the following Specific Aims and Hypotheses: 1. To determine in menstruating women ages 18-45 whether an OCP containing ethinyl estradiol (EE) and the progestin ethinydiol diacetate (ED) increases cortical GABA concentrations as measured using proton magnetic resonance spectroscopy (1H-MRS) above that of an OCP containing EE and the progestin norethindrone (NOR). 2. To determine the relationship between changes in occipital GABA concentrations with acute OCP administration and negative affect with chronic OCP administration over two menstrual cycles.
Interventions
- OTHER oral contraceptive pill (OCP; OCPs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-03 |
Why NCT00656318 stopped before completion
NCT00656318 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which oral contraceptive pill (OCP; OCPs) is the first listed.
NCT00656318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00656318 about?
NCT00656318 is a clinical study titled "Impact of Oral Contraceptives on GABA and Neurosteroids". Thus, the proposed study has the following Specific Aims and Hypotheses: 1. To determine in menstruating women ages 18-45 whether an OCP containing ethinyl estradiol (EE) and the progestin ethinydiol diacetate (ED) increases cortical GABA concentrations as measured using proton magnetic resonance s...
What is the current status of trial NCT00656318?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2008-08. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00656318?
The interventions under investigation include: oral contraceptive pill (OCP; OCPs) (OTHER).
Who is sponsoring clinical trial NCT00656318?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia